Backers of a bill that is meant to put all matters related to use of drugs and medications in American thoroughbred racing under the US Anti-Doping Agency have been put before members of the Congressional Horse Caucus.
2. Backers of a bill that is meant to put all matters related to
use of drugs and medications in American thoroughbred
racing under the US Anti-Doping Agency have been put
before members of the Congressional Horse Caucus.
The Thoroughbred Horseracing Integrity Act of 2015 (HR
3084) proposes that all rule-making, testing, and
enforcement as it relates to drugs and medications must
be placed under the jurisdiction of an entity created under
the United States Anti-Doping Agency. Supporters of the
bill are hopeful that they will manage to get the bill a
Congressional committee or sub-committee that would be
an important step towards getting it passed into law.
3. The bill presently has the support of 33 bipartisan members from the
House of Representatives, including cosponsors from California, New
Jersey, New York, Connecticut, Florida, Illinois, Indiana, Kentucky,
Maryland, Ohio, and South Carolina. Representatives of the industry
were sent invitation for participating in the panel in Washington DC
by Congressional Horse Caucus co-chairmen Andy Barr (R-Ky.) and
Paul Tonko (D-N.Y.), who introduced the bipartisan bill last July. This
hearing is seen by many as an educational opportunity for members of
Horse Caucus and the industry for examining the legislation.
Panelists who spoke included National Horsemen’s Benevolent and
Protective Association chief executive Eric Hamelback, racehorse
owner/professional chef Bobby Flay, former Maryland Jockey Club
owner Joe De Francis, Breeders Cup Ltd president and chief executive
Craig Fravel, and Chauncey Morris, who is executive director of the
Kentucky Thoroughbred Association and Kentucky Thoroughbred
Owners and Breeders Inc.